{"id":"https://openalex.org/W4396591641","doi":"https://doi.org/10.1158/1538-7445.sabcs23-po5-15-09","title":"Abstract PO5-15-09: DNA damage induced necroptosis predicts response to radioimmunotherapy","display_name":"Abstract PO5-15-09: DNA damage induced necroptosis predicts response to radioimmunotherapy","publication_year":2024,"publication_date":"2024-05-02","ids":{"openalex":"https://openalex.org/W4396591641","doi":"https://doi.org/10.1158/1538-7445.sabcs23-po5-15-09"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs23-po5-15-09","doi":"https://doi.org/10.1158/1538-7445.sabcs23-po5-15-09","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.sabcs23-po5-15-09","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013892278","display_name":"Anna M. Goddard","orcid":"https://orcid.org/0000-0001-5681-1521","observed_orcids":["https://orcid.org/0000-0001-5681-1521"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna Goddard","raw_affiliation_strings":["1University of North Carolina, North Carolina, United States;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina, North Carolina, United States;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Qinhong Wang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qinhong Wang","raw_affiliation_strings":["2University of North Carolina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of North Carolina;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109711878","display_name":"Minguk Cho","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Minguk Cho","raw_affiliation_strings":["2University of North Carolina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of North Carolina;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070842981","display_name":"Lynn M. Lerner","orcid":"https://orcid.org/0009-0006-4405-7334","observed_orcids":["https://orcid.org/0009-0006-4405-7334"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lynn Lerner","raw_affiliation_strings":["2University of North Carolina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of North Carolina;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112864074","display_name":"Gaorav P. Gupta","orcid":"https://orcid.org/0000-0001-9177-552X","observed_orcids":["https://orcid.org/0000-0001-9177-552X"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gaorav Gupta","raw_affiliation_strings":["3University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"9_Supplement","first_page":"PO5","last_page":"15"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/radioimmunotherapy","display_name":"radioimmunotherapy","score":0.8500000238418579},{"id":"https://openalex.org/keywords/necroptosis","display_name":"necroptosis","score":0.8009999990463257},{"id":"https://openalex.org/keywords/abscopal-effect","display_name":"abscopal effect","score":0.8130000233650208},{"id":"https://openalex.org/keywords/mre11","display_name":"MRE11","score":0.8460000157356262},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.8790000081062317},{"id":"https://openalex.org/keywords/cgas-sting-pathway","display_name":"cGAS-STING pathway","score":0.7870000004768372},{"id":"https://openalex.org/keywords/zbp1","display_name":"ZBP1","score":0.7179999947547913},{"id":"https://openalex.org/keywords/ripk3","display_name":"RIPK3","score":0.8579999804496765},{"id":"https://openalex.org/keywords/mlkl","display_name":"MLKL","score":0.9610000252723694},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.6050000190734863},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-resistance","display_name":"immune checkpoint inhibitor resistance","score":0.7300000190734863},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.6850000023841858},{"id":"https://openalex.org/keywords/spatial-transcriptomics","display_name":"spatial transcriptomics","score":0.7720000147819519},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.6610000133514404},{"id":"https://openalex.org/keywords/systemic-antitumor-immunity","display_name":"systemic antitumor immunity","score":0.7070000171661377}],"concepts":[{"id":"https://openalex.org/C94030615","wikidata":"https://www.wikidata.org/wiki/Q3346925","display_name":"Necroptosis","level":4,"score":0.9399576187133789},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.9287000894546509},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.613879382610321},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.544533908367157},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41239264607429504},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.3013152778148651},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29057595133781433},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.289339542388916},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.2485153079032898},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23413929343223572},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.113382488489151},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.05188944935798645},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs23-po5-15-09","doi":"https://doi.org/10.1158/1538-7445.sabcs23-po5-15-09","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.sabcs23-po5-15-09","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4387206897","https://openalex.org/W2793264505","https://openalex.org/W3138225123","https://openalex.org/W3157485004","https://openalex.org/W1971339571","https://openalex.org/W4415900320","https://openalex.org/W2153193885","https://openalex.org/W4391102303","https://openalex.org/W4404064808","https://openalex.org/W2509576306"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"More":[2],"than":[3],"half":[4],"of":[5,45,73,89,98,106,130,220,264,338,345,365,378,409,459,464,490,539],"all":[6,40],"cancer":[7,14,139,448,502],"patients":[8],"receive":[9],"radiotherapy":[10],"(RT)":[11],"during":[12],"their":[13],"experience.":[15],"DNA":[16,56,491,528],"damage":[17,57,492,529],"induced":[18,268,277,421,493,530],"by":[19,269,422],"RT":[20,117,178],"can":[21,91],"initiate":[22],"a":[23,354,507],"pro-inflammatory":[24],"immune":[25,241,339],"response":[26,34,352,396,453,485,499,511,533],"within":[27],"the":[28,46,55,82,107,128,196,228,315,321,379,413,437,443,540],"tumor":[29,145,235,238,250,407],"microenvironment":[30],"(TME),":[31],"yet":[32],"this":[33,99],"is":[35,43,67,101],"not":[36,200,276],"uniformly":[37],"observed":[38],"across":[39,262],"tumors.":[41],"Mre11":[42,66],"one":[44,183],"first":[47],"responders":[48],"to":[49,80,102,118,150,182,190,257,330,441,454,486,512,534],"double":[50],"stranded":[51],"breaks":[52],"and":[53,122,148,154,165,237,249,286,295,326,399,402,417,430,461,481],"coordinates":[54],"response.":[58,133,445],"Recent":[59],"work":[60],"in":[61,76,127,271,278,311,314,320,333,342,357,376,436,468,474,484,495,500],"our":[62],"lab":[63],"reveals":[64],"that":[65,274,372],"required":[68],"for":[69,245,289,510],"cGAS":[70],"mediated":[71,94,381],"detection":[72],"cytoplasmic":[74],"DNA,":[75],"turn":[77],"activating":[78],"STING":[79],"engage":[81],"type":[83,393],"I":[84],"interferon":[85,380,385,389,395,479],"signaling":[86,382,480],"pathway,":[87,426],"downstream":[88],"which":[90,465],"activate":[92],"ZBP1/RIPK3/MLKL":[93],"necroptosis.":[95],"The":[96,309,424,472,488],"purpose":[97],"study":[100],"determine":[103],"if":[104],"expression":[105,207,260,359,458],"necroptotic":[108,425],"pathway":[109,325,383],"may":[110],"predict":[111],"whether":[112],"breast":[113,138,213,410,501],"tumors":[114,164,221,313,332,348,439],"benefit":[115],"from":[116,368],"overcome":[119],"ICI":[120,152],"resistance":[121,149],"induce":[123],"systemic":[124],"anti-tumor":[125],"immunity":[126],"form":[129],"an":[131,350,451,497],"abscopal":[132,188,211,272,316,351,369,414,444,452,498],"Methods:":[134],"Four":[135],"Trp53-/-":[136],"Balb/c":[137],"syngeneic":[140],"allograft":[141],"models":[142,273,280,317,370,449,476],"with":[143,162,210,450],"low":[144],"mutational":[146],"burden":[147],"dual":[151],"(anti-PD1":[153],"anti-CTLA4,":[155],"BioXcell)":[156],"were":[157,160,275,281,298],"used.":[158],"Mice":[159],"implanted":[161],"bilateral":[163],"randomly":[166],"divided":[167],"into":[168],"four":[169],"treatment":[170,226,247,374],"cohorts:":[171],"untreated,":[172],"RT,":[173],"ICI,":[174],"or":[175],"RT+ICI,":[176],"where":[177],"(8Gyx3)":[179],"was":[180,255],"administered":[181],"tumor.":[184],"Two":[185],"lines":[186],"exhibited":[187],"responses":[189],"RT+ICI":[191,270,346,373,455,513],"(i.e.,":[192,201],"\u201cabscopal":[193],"models\u201d),":[194],"whereas":[195],"other":[197],"two":[198],"did":[199],"\u201cnon-abscopal":[202],"models\u201d).":[203],"To":[204],"identify":[205,258],"gene":[206,259,304,358],"patterns":[208,261],"associated":[209],"responding":[212],"tumors,":[214],"we":[215],"performed":[216,256,299],"spatial":[217],"transcriptomic":[218],"analysis":[219,297,364],"10":[222],"days":[223],"after":[224,361],"initiating":[225],"using":[227,283,300],"GeoMx":[229],"whole":[230],"transcriptome":[231],"assay":[232],"targeting":[233],"panCK+":[234,438],"cells":[236,242,408],"adjacent":[239],"CD45+":[240,343,366],"(N":[243],">5":[244],"each":[246],"group":[248],"type).":[251],"Unsupervised":[252],"hierarchical":[253],"clustering":[254,337],"areas":[263],"interest.":[265],"Genes":[266],"selectively":[267],"non-abscopal":[279,334],"identified":[282],"two-tailed":[284],"t-test":[285],"FDR":[287],"correction":[288],"multiple":[290],"testing":[291],"(FDR<":[292],"5%).":[293],"DeSEQ2":[294],"GSEA":[296,363],"publicly":[301],"available":[302],"mouse":[303],"sets":[305],"(Broad":[306],"Institute).":[307],"Results:":[308],"TME":[310,473],"untreated":[312,331],"demonstrate":[318,442,456],"upregulation":[319],"B":[322],"cell":[323],"survival":[324],"apoptotic":[327],"pathways":[328],"compared":[329],"models.":[335],"Hierarchical":[336],"related":[340],"genes":[341],"segments":[344,367],"treated":[347],"exhibiting":[349],"revealed":[353],"global":[355],"shift":[356],"profiles":[360],"treatment.":[362],"shows":[371],"results":[375],"enrichment":[377],"including":[384,427],"alpha":[386],"(p<":[387,391,397,404],"0.0001),":[388,392,398],"beta":[390],"II":[394],"antigen":[400,482],"processing":[401],"presentation":[403,483],"0.0001).":[405],"In":[406],"cancers":[411],"demonstrating":[412],"response,":[415],"Isg15":[416,460],"Zbp1":[418],"are":[419,432,466],"highly":[420],"RT+ICI.":[423,487],"Zbp1,":[428,462],"Ripk3,":[429],"Mlkl,":[431],"significantly":[433],"higher":[434,457],"expressed":[435],"known":[440],"Conclusion:":[446],"Breast":[447,544],"both":[463],"involved":[467],"secreted":[469],"inflammatory":[470],"signaling.":[471],"these":[475],"have":[477],"increased":[478],"role":[489],"necroptosis":[494,531],"generating":[496],"warrants":[503],"further":[504],"investigation":[505],"as":[506],"potential":[508],"biomarker":[509],"combination":[514],"therapy.":[515],"Citation":[516],"Format:":[517],"Anna":[518],"Goddard,":[519],"Qinhong":[520],"Wang,":[521],"Minguk":[522],"Cho,":[523],"Lynn":[524],"Lerner,":[525],"Gaorav":[526],"Gupta.":[527],"predicts":[532],"radioimmunotherapy":[535],"[abstract].":[536],"In:":[537],"Proceedings":[538],"2023":[541,547],"San":[542,550],"Antonio":[543],"Cancer":[545,556],"Symposium;":[546],"Dec":[548],"5-9;":[549],"Antonio,":[551],"TX.":[552],"Philadelphia":[553],"(PA):":[554],"AACR;":[555],"Res":[557],"2024;84(9":[558],"Suppl):Abstract":[559],"nr":[560],"PO5-15-09.":[561]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2024-05-03T00:00:00"}